Form 4: Amarin Director Diane Sullivan Reports RSU Vesting

Director Diane E. Sullivan acquired 838 American Depositary Shares through the vesting of restricted stock units and withheld 403 shares for tax obligations.

Summary

• Director Diane E. Sullivan acquired 838 American Depositary Shares (ADS) on April 18, 2026, following the vesting of restricted stock units (RSUs).
• The company withheld 403 shares to satisfy tax liabilities associated with the vesting event.
• The transaction resulted in a net increase in beneficial ownership, bringing the total to 836 ADS held directly.
• The reporting reflects adjustments made for the company's previous ADS ratio change implemented on April 11, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine director equity compensation.

Positives

• Director maintains a direct equity stake in the company, aligning interests with shareholders.

Negatives

• The transaction involved a tax-related withholding of shares, which is a standard administrative procedure rather than a market-driven divestment.

Risks

• The company is subject to ongoing equity award volatility and potential dilution from stock incentive plans.

Future Outlook

The remaining RSUs are scheduled to vest on April 18, 2027, per the original grant terms.

Industry Context

StockSavvy.ai notes that this filing is a routine disclosure of director equity compensation, common in the pharmaceutical sector to ensure transparency in executive and board-level share ownership.

Comparison to Industry Standards

• The use of RSU vesting and tax withholding is standard practice for executive compensation among mid-cap pharmaceutical companies.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Final vesting of remaining RSU installments scheduled for April 18, 2027.

Key Dates

Keywords

Amarin, AMRN, Form 4, Insider Trading, Equity Compensation, Director Ownership